InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Protecting life science patents in Latin America


Regimes for protecting pharmaceutical and biotechnological products via patents are slowly but steadily improving in many Latin American countries. Managing IP invited Alejandro Luna of Olivares & Ci­a, Guillermo Carey of HarneckerCarey Carey y Cía and in-house counsel Regina Kuchle to discuss some promising developments and continuing challenges

EM: What regulatory changes have most impacted biotechnology and pharmaceutical patents recently? AL: There was an amendment to the Mexican General Health Law in June 2009 which defined biotechnological drugs and allowed for the approval of follow-on biologics, or biocomparables. ...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null

null null null

null null null

Mid Year 2018

PTAB practice in a post-SAS world

The big questions remaining after the Supreme Court’s SAS ruling include how institution rates will change, how strategy at the Board should evolve, and how district courts and the Federal Circuit will react. Michael Loney investigates



Most read articles

Supplements